Table of Content

1. Introduction to Cancer Vaccines


2. Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism


3. Global Cancer Vaccine Market Overview
3.1 Current Market Scenario
3.2 Future Market Opportunity


4. Cancer Vaccine Market Insight by Region
4.1 US
4.2 Europe
4.3 China
4.4 Japan
4.5 India
4.6 South Korea
4.7 Australia
4.8 Cuba
4.9 Canada
4.10 UK


5. Cancer Vaccine Market Insight by Indication
5.1 Human papillomavirus Associated Cancer
5.2 Lung Cancer
5.3 Pancreatic Cancer
5.4 Prostate Cancer
5.5 Bladder Cancer
5.6 Melanoma
5.7 Breast Cancer
5.8 Colorectal Cancer
5.9 Glioblastoma
5.10 Ovarian Cancer


6. Approved Cancer Vaccines – Price, & Dosage Analysis

This Chapter Give Insight On 11 Cancer Vaccine Commercially Available In Market


7. Global Cancer Vaccines Clinical Pipeline Overview
7.1 By Company
7.2 By Country
7.3 By Patient Segment/Disease Stage
7.4 By Phase


8. Global Cancer Vaccines Clinical Trials Insight By Company, Indication & Phase
8.1 Research
8.2 Preclinical
8.3 Clinical
8.4 Phase-I
8.5 Phase-I/II
8.6 Phase-II
8.7 Phase-III/II
8.8 Phase-III
8.9 Preregistration
8.10 Registered


9. Marketed Cancer Vaccines Clinical Insight By Company & Indication


10. Competitive Landscape
10.1 Anixa Bioscience
10.2 Argos Therapeutics
10.3 AstraZeneca
10.4 BioNTech
10.5 Bristol Myers Squibb
10.6 Champions Oncology
10.7 CureVac
10.8 Elicio Therapeutics
10.9 ETheRNA
10.10 GlaxoSmithKline
10.11 ImmunityBio
10.12 Imugene
10.13 In3Bio
10.14 Merck
10.15 Mayo Clinic
10.16 Nykode Therapeutics
10.17 Regeneron?
10.18 Roche
10.19 TVAX Biomedical
10.20 UbiVac
10.21 Ultimovacs
10.22 VBI vaccines